Diagnostic challenges of cryptococcal infection in patients with HIV: disseminated cryptococcosis with discordant blood and cerebrospinal fluid microbiology

Authors

  • Karla del Rocio Moreno-Alvarez Universidad Ecotec, Samborondon, Ecuador
  • Angel O. Diaz-Pincay Universidad Ecotec, Samborondon, Ecuador

DOI:

https://doi.org/10.54034/mic.e2711

Keywords:

HIV infections, cryptococcus neoformans, opportunistic infections, cerebrospinal fluid, immune reconstitution inflammatory syndrome

Abstract

Background: Cryptococcal infection remains a major cause of morbidity and mortality in people with advanced HIV disease, particularly in settings with delayed diagnosis and limited access to specialized diagnostics. Diagnostic uncertainty may arise when systemic microbiological evidence is present despite non-confirmatory cerebrospinal fluid findings. Case presentation: We report the case of a 54-year-old man with recently diagnosed advanced HIV infection who presented with persistent headache, fever, and later dyspnea. Immunological evaluation showed severe immunosuppression, with an HIV viral load of 84,481 copies/mL and a CD4+ T-cell count of 32 cells/µL. Blood cultures grew Cryptococcus neoformans, confirming disseminated cryptococcal infection. However, repeated cerebrospinal fluid studies showed low glucose and markedly low cellularity but remained negative by Gram stain, potassium hydroxide preparation, Ziehl–Neelsen stain, and culture. The patient received amphotericin B followed by fluconazole consolidation, together with prophylaxis for opportunistic infections. Antiretroviral therapy was initiated after antifungal stabilization. The patient subsequently improved clinically, and no immune reconstitution inflammatory syndrome was reported during follow-up. Conclusions: This case highlights the diagnostic discordance that may occur in advanced HIV-associated cryptococcal infection and underscores that negative cerebrospinal fluid microbiology does not exclude clinically significant disease in profoundly immunocompromised patients. In low-resource settings, blood-based microbiology and integrated clinical reasoning may be decisive for diagnosis and treatment.

References

1. Chang CC, Harrison TS, Bicanic T, Chayakulkeeree M, Sorrell TC, Warris A, et al. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024;24(8):e495-e512. doi:10.1016/S1473-3099(23)00731-4.

2. McHale TC, Boulware DR, Kasibante J, Ssebambulidde K, Skipper CP, Abassi M. Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clin Microbiol Rev. 2023;36(4):e00156-22. doi: 10.1128/cmr.00156-22.

3. Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal antigenemia in advanced human immunodeficiency virus disease: pathophysiology, epidemiology, and clinical implications. Clin Infect Dis. 2023;76(4):764-770. doi:10.1093/cid/ciac675.

4. Farfán-Cano GG, Farfán-Cano SG, Farfán-Cano HR, Silva-Rojas GA. HIV-associated opportunistic infections. Rev Cien Ecu. 2022;4(4):1-8. doi:10.23936/rce.v4i4.71.

5. Farfan-Cano GG, Farfán-Cano SG, Farfán-Cano HR. Emotional and clinical challenges of delayed HIV seroconversion: case study. Futurity Medicine. 2024; 3(3): 28-35. doi: 10.57125/FEM.2024.09.30.03.

6. Farfán-Cano GG. Challenges in HIV monitoring: insights from cluster of differentiation 4 variability in resource-limited settings. Microbiol Infect Dis AMJ. 2025;3(1):85-91. doi: 10.33590/microbiolinfectdisam/XERL7547.

7. Lehman A, Ellis J, Nalintya E, Bahr NC, Loyse A, Rajasingham R. Advanced HIV disease: a review of diagnostic and prophylactic strategies. HIV Med. 2023;24(8):859-876. doi:10.1111/hiv.13487.

8. Falconer J, Mmotsa TM, Govender NP, Jarvis JN. Diagnosis of cryptococcal meningitis in people living with HIV in low-income countries: barriers and strategies. Expert Rev Anti Infect Ther. 2025;23(10):893-905. doi: 10.1080/14787210.2025.2554999.

9. Meya DB, Williamson PR. Cryptococcal disease in diverse hosts. N Engl J Med. 2024;390(17):1597-1610. doi: 10.1056/NEJMra2311057.

10. Boulware DR, Jarvis JN. Timing of antiretroviral therapy in cryptococcal meningitis: what we can (and cannot) learn from observational data. Clin Infect Dis. 2023;77(1):74-76. doi:10.1093/cid/ciad123.

11. Shi ZW, Chen Y, Ogoke KM, Strickland AB, Shi M. Cryptococcal immune reconstitution inflammatory syndrome: from clinical studies to animal experiments. Microorganisms. 2022;10(12):2419. doi: 10.3390/microorganisms10122419.

Published

2026-06-18

Issue

Section

CLINICAL CASES

How to Cite

1.
Diagnostic challenges of cryptococcal infection in patients with HIV: disseminated cryptococcosis with discordant blood and cerebrospinal fluid microbiology. Microbes Infect. Chemother. [Internet]. 2026 Jun. 18 [cited 2026 Aug. 12];6:e2711. Available from: https://revistas.unheval.edu.pe/index.php/mic/article/view/2711

Similar Articles

1-10 of 77

You may also start an advanced similarity search for this article.